208 related articles for article (PubMed ID: 34062411)
1. The complex roles of efferocytosis in cancer development, metastasis, and treatment.
Tajbakhsh A; Gheibi Hayat SM; Movahedpour A; Savardashtaki A; Loveless R; Barreto GE; Teng Y; Sahebkar A
Biomed Pharmacother; 2021 Aug; 140():111776. PubMed ID: 34062411
[TBL] [Abstract][Full Text] [Related]
2. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
Myers KV; Amend SR; Pienta KJ
Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
[TBL] [Abstract][Full Text] [Related]
3. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
[TBL] [Abstract][Full Text] [Related]
4. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
[TBL] [Abstract][Full Text] [Related]
5. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
6. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
[TBL] [Abstract][Full Text] [Related]
7. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
[TBL] [Abstract][Full Text] [Related]
8. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.
Yang M; Liu J; Piao C; Shao J; Du J
Cell Death Dis; 2015 Jun; 6(6):e1780. PubMed ID: 26068788
[TBL] [Abstract][Full Text] [Related]
9. Regulation of efferocytosis as a novel cancer therapy.
Zhou Y; Yao Y; Deng Y; Shao A
Cell Commun Signal; 2020 May; 18(1):71. PubMed ID: 32370748
[TBL] [Abstract][Full Text] [Related]
10. RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer.
Zhou X; Li D; Xia S; Ma X; Li R; Mu Y; Liu Z; Zhang L; Zhou Q; Zhuo W; Ding K; Lin A; Liu W; Liu X; Zhou T
J Control Release; 2024 Feb; 366():128-141. PubMed ID: 38104775
[TBL] [Abstract][Full Text] [Related]
11. Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
Lin D; Kang X; Shen L; Tu S; Lenahan C; Chen Y; Wang X; Shao A
Mol Ther Oncolytics; 2020 Jun; 17():394-407. PubMed ID: 32346605
[TBL] [Abstract][Full Text] [Related]
12. A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies.
Bravo DD; Shi Y; Sheu A; Liang WC; Lin W; Wu Y; Yan M; Wang J
J Immunol; 2023 Apr; 210(8):1166-1176. PubMed ID: 36881873
[TBL] [Abstract][Full Text] [Related]
13. Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis.
Wei YT; Wang XR; Yan C; Huang F; Zhang Y; Liu X; Wen ZF; Sun XT; Zhang Y; Chen YQ; Gao R; Pan N; Wang LX
Cancer Res; 2022 May; 82(10):1991-2002. PubMed ID: 35364609
[TBL] [Abstract][Full Text] [Related]
14. Efferocytosis in the tumor microenvironment.
Werfel TA; Cook RS
Semin Immunopathol; 2018 Nov; 40(6):545-554. PubMed ID: 30187085
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Osteoblastic Cell Efferocytosis by Bone Marrow Macrophages.
Michalski MN; Koh AJ; Weidner S; Roca H; McCauley LK
J Cell Biochem; 2016 Dec; 117(12):2697-2706. PubMed ID: 27061191
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.
Roy S; Bag AK; Dutta S; Polavaram NS; Islam R; Schellenburg S; Banwait J; Guda C; Ran S; Hollingsworth MA; Singh RK; Talmadge JE; Muders MH; Batra SK; Datta K
Cancer Res; 2018 Oct; 78(19):5600-5617. PubMed ID: 30111533
[TBL] [Abstract][Full Text] [Related]
17. Macrophage efferocytosis in health and disease.
Razi S; Yaghmoorian Khojini J; Kargarijam F; Panahi S; Tahershamsi Z; Tajbakhsh A; Gheibihayat SM
Cell Biochem Funct; 2023 Mar; 41(2):152-165. PubMed ID: 36794573
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis.
Werfel TA
Methods Mol Biol; 2022; 2543():45-55. PubMed ID: 36087258
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment.
Cruz Cruz J; Allison KC; Page LS; Jenkins AJ; Wang X; Earp HS; Frye SV; Graham DK; Verneris MR; Lee-Sherick AB
Front Immunol; 2023; 14():1146721. PubMed ID: 36960055
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation.
Chang HY; Lee HN; Kim W; Surh YJ
Life Sci; 2015 Jan; 120():39-47. PubMed ID: 25445227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
